ANGLE Share Price (AGL)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 79.00on 18-10-2019 at 16:30:00
Change -0.50 -0.63%
Buy 80.00
Sell 78.00
Buy / Sell AGL Shares
Sponsored Financial Content
Last Trade: Buy 3,733 at 79.70p
Day's Volume: 38,036
Last Close: 79.50p
Open: 79.50p
ISIN: GB0034330679
Day's Range 79.00p - 79.00p
52wk Range: 38.00p - 84.50p
Market Capitalisation: £136m
VWAP: 0.00p
Shares in Issue: 173m

Recent Trades History ANGLE (AGL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy*3,73379.70Ordinary
16:04:51 - 18-Oct-19
Buy*12,56979.56Ordinary
14:42:44 - 18-Oct-19
Sell*5,00078.10Ordinary
14:23:16 - 18-Oct-19
Unknown*2,99979.00Uncrossing Trade
14:00:07 - 18-Oct-19
Sell*5,00078.25Ordinary
13:53:01 - 18-Oct-19
Buy*11079.56Ordinary
13:09:07 - 18-Oct-19
Sell*5,00079.10Ordinary
10:52:39 - 18-Oct-19
Sell*3,62579.001Ordinary
09:32:48 - 18-Oct-19
Buy*35,00080.00Ordinary
Delayed publication
16:30:57 - 17-Oct-19
Buy*29,44480.00Ordinary
Delayed publication
16:07:24 - 17-Oct-19

Share Price History for ANGLE

Time period:
to
Date Open High Low Close
17th Oct 2019 (Thu)79.0079.5079.0079.50
16th Oct 2019 (Wed)79.0080.0079.0079.00
15th Oct 2019 (Tue)78.7079.2078.7079.00
14th Oct 2019 (Mon)78.2080.0079.6078.70
11th Oct 2019 (Fri)78.0078.2075.8078.20
10th Oct 2019 (Thu)78.0078.0078.0078.00
9th Oct 2019 (Wed)78.5080.0076.9078.00
8th Oct 2019 (Tue)77.5078.5075.0078.50
7th Oct 2019 (Mon)78.0078.0077.5077.50
4th Oct 2019 (Fri)78.5079.5078.0078.00
3rd Oct 2019 (Thu)81.5081.5077.5077.50
2nd Oct 2019 (Wed)83.0083.0081.3081.50
1st Oct 2019 (Tue)82.0083.0082.0083.00
30th Sep 2019 (Mon)82.0082.0082.0082.00
27th Sep 2019 (Fri)82.0082.0082.0082.00
26th Sep 2019 (Thu)82.0082.0081.5081.50
25th Sep 2019 (Wed)81.8082.0080.8082.00
24th Sep 2019 (Tue)82.0082.0081.8081.80
23rd Sep 2019 (Mon)82.5083.0082.0082.00
20th Sep 2019 (Fri)81.0083.5081.0082.50

News about ANGLE (AGL)

University of Birmingham finds Angle's Liquid biopsy system holds key advantages over rivals to treat head and neck cancer

News - Friday, September 13, 2019

Liquid biopsy company Angle said the University of Birmingham had published research indicating the potential of using CTC liquid biopsies to improve treatment of head and neck cancer and found that the company's liquid biopsy system held key advantages over other liquid biopsy systems. Key advantages of Angle's Parsortix system, over traditional tissue biopsies, included the ability to repeat the investigation at multiple time points and a reduction in overall healthcare costs, according to the research published by the University of Birmingham. 'Identified advantages of the Parsortix system, over other CTC liquid biopsy systems, are that it is not antibody-dependent and is able to detect all sub-populations of CTCs as well as CTC clusters,' the research noted. ...

FTSE 100 Latest
Value7,150.57
Change-31.75


Login to your account

Forgot Password?

Not Registered